David R. Darley

Individual Participant Data Meta-Analysis (IPDMA) of long-term COVID-19 outcomes in a systematic review-informed, international, multidisciplinary database.

Journal: Health and social care delivery research

Published: August 28, 2026

Baseline Lung Allograft Dysfunction: Definition, Timing, and Implications for Outcomes-an ISHLT Consensus Document.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: May 25, 2026

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: April 14, 2026

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 23, 2026

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 23, 2026

The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: December 06, 2025

The ASSIST CLAD Study: A Phase 2 Randomized Controlled Trial of Mesenchymal Stromal Cells for New-Onset Chronic Lung Allograft Dysfunction.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: December 06, 2025

Proteomic Analysis of Transbronchial Biopsies to Discover Novel Biomarkers for Early Identification of Chronic Lung Allograft Dysfunction.

Journal: Transplantation direct

Published: December 23, 2024

Proteomic Analysis of Transbronchial Biopsy Tissue Reveals a Distinct Proteome and Mechanistic Pathways in High-Grade Eosinophilic Inflammation After Lung Transplantation.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: November 18, 2024

Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era.

Journal: Open forum infectious diseases

Published: September 17, 2024

Individual Participant Data Meta-Analysis (IPDMA) of long-term COVID-19 outcomes in a systematic review-informed, international, multidisciplinary database.

Individual Participant Data Meta-Analysis (IPDMA) of long-term COVID-19 outcomes in a systematic review-informed, international, multidisciplinary database.

Baseline Lung Allograft Dysfunction: Definition, Timing, and Implications for Outcomes-an ISHLT Consensus Document.

Baseline Lung Allograft Dysfunction: Definition, Timing, and Implications for Outcomes-an ISHLT Consensus Document.

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction.

The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction.

The ASSIST CLAD Study: A Phase 2 Randomized Controlled Trial of Mesenchymal Stromal Cells for New-Onset Chronic Lung Allograft Dysfunction.

The ASSIST CLAD Study: A Phase 2 Randomized Controlled Trial of Mesenchymal Stromal Cells for New-Onset Chronic Lung Allograft Dysfunction.

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

Acute tacrolimus toxicity due to concomitant use of ritonavir (with nirmatrelvir as Paxlovid).

Acute tacrolimus toxicity due to concomitant use of ritonavir (with nirmatrelvir as Paxlovid).

Proteomic Analysis of Transbronchial Biopsies to Discover Novel Biomarkers for Early Identification of Chronic Lung Allograft Dysfunction.

Proteomic Analysis of Transbronchial Biopsies to Discover Novel Biomarkers for Early Identification of Chronic Lung Allograft Dysfunction.

Proteomic Analysis of Transbronchial Biopsy Tissue Reveals a Distinct Proteome and Mechanistic Pathways in High-Grade Eosinophilic Inflammation After Lung Transplantation.

Proteomic Analysis of Transbronchial Biopsy Tissue Reveals a Distinct Proteome and Mechanistic Pathways in High-Grade Eosinophilic Inflammation After Lung Transplantation.

Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era.

Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era.